Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1062
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWadhwa, Ridhima-
dc.contributor.authorAggarwal, Taru-
dc.contributor.authorChandra, Pranjal-
dc.contributor.authorYadav, Pooja-
dc.contributor.authorMaurya, Pawan Kumar-
dc.contributor.authorKumari, Vandana-
dc.contributor.authorReddy, Boda Sai Charan-
dc.date.accessioned2023-05-01T18:26:17Z-
dc.date.available2023-05-01T18:26:17Z-
dc.date.issued2019-
dc.identifier.urihttp://hdl.handle.net/123456789/1062-
dc.description.abstractBlood and the linings of blood vessels may be regarded as a fifth tissue type. The human body contains 5 × 109 red blood cells (RBCs) per ml, a total of 2.5 × 1013 cells in the 5 l of blood present in the body. With an average lifetime of 125 days, human RBCs are destroyed by leukocytes in the spleen and liver. Nowadays red blood cells are extensively used to study various metabolic functions. Nanoparticles (NP) are being widely accepted for drug delivery system. This review summarizes the red blood cells, NPs and their characteristics on the basis of the RBC components along with drug delivery systems through RBCs. Further, we also discussed that how erythrocytes can be used as an efficient in vitro model for evaluating the efficacy of various nanocomposite materials.en_US
dc.language.isoenen_US
dc.publisher3 Biotechen_US
dc.subjectRed blood cells · Nanoparticles · Drug delivery system · Fabricationen_US
dc.titleRed blood cells as an efficient in vitro model for evaluating the efficacy of metallic nanoparticlesen_US
dc.typeArticleen_US
Appears in Collections:School of Interdisciplinary & Applied Sciences

Files in This Item:
File Description SizeFormat 
Red blood cells as an efficient in vitro model for evaluating the efficacy.pdf1.04 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.